Advanced search
Publication Cover
Pathology Volume 31, 1999 - Issue 4
Submit an article Journal homepage
8
Views
1
CrossRef citations to date
0
Altmetric
Research Article

The Use of Flow Cytometry in the Diagnosis and Monitoring of Malignant Hematological Disorders

Mitchell S. Ward Haematology Department, Royal Perth Hospital, WA, Australia
Pages 382-392 | Published online: 06 Jul 2009

  • Schlossman SF, Boumsell L. Gilks W. et al., editors. Leukocyte typing V: white cell differentiation antigens. London: Oxford University Press. 1995.
  • Borowitz MJ, Bray R, Gascoyne R, et al. U.S.-Canadian consensus recommendations on the immunophenotypic analysis of hematological neoplasia by flow cytometry: data analysis and interpretation. Cytometry (Commun Clin Cytometry) 1997; 30: 236-44.
  • Tbakhi A, EdingerM, Myles J, et at. Flow cytometric immunophenotyping of non-Hodgkin's lymphomas and related disorders. Cytometry 1996;25: 113-24.
  • Rowan RM, Bain BJ, England JM, et al., for the General Haematology Task Force of BCSH. Immunophenotyping in the diagnosis of acute leukaemias. J Clin Pathol 1994; 47: 777-81.
  • Farahat N, van der Plas D, Praxedes M, et al. Demonstration of cytoplasmic and nuclear antigens in acute leukaemia using flow cytometry. 1 Clin Pathol 1994; 47: 843-9.
  • Bene MC, Castoldi G, Knapp W, et al., (EGIL group). Proposals for the immunological classification of acute leukaemias. Leukaemia 1995; 9: 1783-6.
  • Keren DF, Hanson CA, Hurtubise PE, editors. Analysis of leukaemia and lymphoma. In: Flow cytometry and cUncial diagnosis. Chicago: ASCP Press. 1994; 225-6.
  • Borowitz MJ, Guenther KL, Shults KE, Stelzer GT. Immunophenotyping of acute leukaemia by flow cytometric analysis. Use of CD45 and right-angle light scatter to gate leukaemic blasts in three-colour analysis. Am J Clin Pathol 1993; 100: 534-40.
  • Harada N, Okamura S, Kubota A, et al. Analysis of acute myeloid leukaemia cells by flow cytometry introducing a new light-scattering classification. J Cancer Res Clin Oncol 1994; 120: 553-7.
  • Campos L, Guyotat D1 Archimbaud E, et al. Surface marker expression in adult acute myeloid leukaemia: correlations with initial characteristics, morphology and response to therapy. Br J Haematol 1989; 72: 161-6.
  • Sperling C, Seibt-Jung H1 Gassman W, et al. Immunophenotyping of acute meyoid leukaemia: correlation with morphological characteristics and therapy response. Recent Results Cancer Res 1993; 131: 381-92.
  • Bennett JM. Catovsky D. Daniel M-T, et al. Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML MO). Br J Haematol 1991; 78: 32S-9.
  • Bennett JM, Catovsky D, Daniel M-T, et al. Criteria for the diagnosis of acute leukaemia of the megakaryocyte lineage (M7). A report of the French-American-British Cooperative Group. Ann Intern Med 1985; 103: 460-2.
  • Del Vecchio L, Di Noto R, Lo Pardo C, et al. lmmunological classification of acute leukaemias: comments on the EGIL proposals. Leukaemia 1996; 10: 1832-3.
  • Ball ED, Davis RB, Griffin JD, et al. Prognostic value of lymphocyte surface markers in acute myeloid leukaemia. Blood 1991; 77: 2242-50.
  • Kita K, Nakase K, Miwa H, et al. Phenotypical characteristics of acute myelocytic leukaemia associated with the t(8;21)(q22;q22) chromosomal abnormality: Frequent expression of immature B-cell antigen CD19 together with stem cell antigen CD34. Blood 1992; 80: 470-7.
  • Ferrara F, Di Noto R, Annunziata M, et al. Immunophenotypic analysis enables the correct prediction of t(8;21) in acute myeloid leukaemia. Br J Haematol 1998; 102: 444-8.
  • Erber WN, Asbahr H, Rule SA, Scott CS. Unique immunophenotype of acute promyelocytic leukaemia as defined by CD9 and CD68 antibodies. Br J Haematol 1994; 88: 101-4.
  • Vahdat L, Maslak P, Miller WH Jr, et al. Early mortality and the retinoic acid syndrome in acute promyelocytic leukaemia: impact of leukocytosis, low-dose chemotherapy, PML/RARa isoform, and CD 13 expression in patients treated with M-trans retinoic acid. Blood 1994; 84: 3843-9.
  • Adriaansen HJ, te Boekhorst PAW, Hagemeijer AM, et al. Acute myeloid leukaemia M4 with bone marrow eosinophilia (M4Eo) and inv(16)(p13q22) exhibits a specific immunophenotype with CD2 expression. Blood 1993; 81: 3043-51.
  • Reading CL, Estey EH, Huh YO, et al. Expression of unusual immunophenotype combinations in acute myelogenous leukaemia. B/ood 1993; 81: 3083-90.
  • Bradstock K, Matthews J, Benson E, et al. for the Australian Leukaemia Study Group. Prognostic value of immunophenotyping in acute myeloid leukaemia. Blood 1994; 84: 1220-5.
  • Paietta E, Andersen J, Yunis J, et al. Acute myeloid leukaemia expressing the leucocyte integrin CDlIb: a new leukaemic syndrome with poor prognosis: results of an ECOG database analysis. Br J Haematol 1998; 100: 265-72.
  • Geller RB, Zahurak M, Hurwitz CA, et al. Prognostic importance of immunophenotying in adults with acute myelocytic leukaemia: the significance of the stem-cell glycoprotein CD34 (MY10). Br J Haematol 1990; 76: 340-7.
  • Solary E, Casanovas RO, Campos L, et al. and the Group d'Etude Immunologique des Leucemies (GEIL). Surface markers in adult acute myeloblastic leukaemia: correlation of CDl9+, CD34+, and CD14*/DR phenotypes with shorter survival. Leukemia 1992; 6: 393-9.
  • Lee EJ, Yang J, Leavitt RD, et al. The significance of CD34 and TdT determinations in patients with untreated de novo acute myeloid leukaemia. Leukaemia 1993; 6: 1203-9.
  • Drexler HG, Thiel E, Ludwig WD. Acute myeloid leukaemias expressing lymphoid-associated antigens: diagnostic incidence and prognostic significance. Leukaemia 1993; 7: 489-98.
  • Cuneo A, Michaux JL, Ferrant A, et al. Correlation of cytogenetic patterns and clinicobiological features in adult acute myeloid leukaemia expressing lymphoid markers. Blood 1992; 79: 720-7.
  • Scott AA. Head DR. Kopecky KJ. et al. HLA-DR-, CD33 +, CD56 +, CD 16-, myeloid/natural killer cell acute leukaemia: a previously unrecognised form of acute leukaemia potentially misdiagnosed as French-American-British acute myeloid leukaemiaM3. Blood 1994; 84: 244-55.
  • Betz SA, Foucar K, Head DR, et al. False-positive flow cytometric platelet glycoprotein Ilb/IIIa expression in myeloid leukaemias secondary to platelet adherence to blasts. Blood 1992; 79: 2399-403.
  • Copelan EA, McGuire EA. The biology and treatment of acute lymphoblastic leukaemia in adults. Blood 1995; 85: 1151-68.
  • Pui CH. Behm FG. Crist WM. Clinical and biologic relevance of immunological marker studies in childhood acute lymphoblastic leukaemia. Blood 1993; 82: 343-62.
  • Boucheix C, David B, Sebban C, et al. Immunophenotyping of adult acute lymphoblastic leukaemia, clinical parameters, and outcome: an analysis of a prospective trial including 562 tested patients (LALA87). Blood 1994; 84: 1603-12.
  • Thomas X, Archimaud E, CharrinC, et al. CD34 expression is associated with major adverse prognostic factors in adult acute lymphoblastic leukaemia. Leukaemia 1995; 9: 249-53.
  • Pui C-H, Hancock ML, Head DR, et al. Clinical significance of CD34 expression in childhood acute lymphoblastic leukaemia. Blood 1993; 82: 889-94.
  • Boldt DH, Kopecky KJ, Head D, et al. Expression of myeloid antigens by blast cells in acute lymphoblastic leukaemia of adults. The South West Oncology Group experience. Leukaemia 1994; 8: 2118-26.
  • Westbrook CA, Hooberman AL, Spino C, et al. Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukaemia: a Cancer and Leukaemia Group B Study (8762). Blood 1992; 80: 2983-90.
  • Shurtleff SA, BuijsA, Behm FG, era/. TEL/AML1 fusion resulting from a cryptic t( 12;21 ) is the most common genetic lesion in pédiatrie ALL and defines a subgroup of patients with an excellent prognosis. Leukaemia 1995; 9: 1985-9.
  • Crist WM, Carroll AJ, Shuster JJ, et al. Poor prognosis of children with pre-B acute lymphoblastic leukaemia is associated with the t(1;19)(q23;p13): a Pediatrie Oncology Group Study. Blood 1990; 76: 117-22.
  • Borowitz MJ, Hunger SP, Carroll AJ, et al. Predictability of the t(l;19)(q23;pl3) from surface antigen phenotype: implications for screening cases of childhood acute lymphoblastic leukaemia for molecular analysis: a Pediatrie Oncology group study. Blood. 1993; 82: 1086-91.
  • Davis RE, Longacre TA, Cornbleet PJ. Hematogones in the bone marrow of adults. Immunophenotypic features, clinical settings, and differential diagnosis. Am J Clin Pathol 1994; 102: 202-11.
  • Traweek ST. Immunophenotypic analysis of acute leukaemia. Am J Clin Pathol 1993; 99: 504-12.
  • Trueworthy R, ShusterJ, Look T, et al. Ploidy of lymphocytes is the strongest predictor of treatment outcome in B-progenitor acute lymphoblastic leukaemia of childhood: a Pedatric Oncology Group Study. J Clin Oncol 1992; 10: 606-13.
  • Pui C-H, Carroll AJ, Raimondi SC, et al. Clinical presentation, karyotypic characterisation, and treatment outcome of childhood acute lymphoblastic leukaemia with a near-normal or hypodiploid less than 45 line. Blood. 1990; 75: 1170-7.
  • Hanson CA, Abaza M, Sheldon S, et al. Acute biphenotypic leukaemia: Immunophenotypic and cytogenetic analysis. Br J Haematol 1993; 84: 49-60.
  • Buccheri V, Matutes E, Dyer MJS, Catovsky D. Lineage commitment in biphenotypic acute leukaemia. Leukaemia 1993; 7: 919-27.
  • Catovsky D, Matutes E, Bucceri V, et al. A classification of acute leukaemia for the 1990s. Ann Haematol 1991; 62: 16-21.
  • Launder TM, Bray RA, Stempora L, et al. Lymphoid-associated antigen expression by acute myeloid leukaemia. Am J Clin Pathol 1996; 106: 185-91.
  • Campana D, Hansen-Hagge T, Matutes E, et al. Phenotypic, genotypic, cytochemical and ultrastructural characterization of acute undifferentiated leukaemia. Leukaemia 1990; 4: 620-4.
  • Testoni N, Martinelli G, Farabegoli P, et al. A new method of "in-cell reverse transcriptase-polymerase chain reaction" for the detection of BCR/ABL transcript in chronic myeloid leukaemia patients. Blood 1996; 87: 3822-7.
  • Jensen IM. Myelopoiesis in myelodysplasia evaluated by multiparameter flow cytometry. Leak Lymphoma 1995; 20: 17-25.
  • Bennett JM, Catovsky D, Daniel M-T, et al. Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. J Clin Pathol 1989; 42: 567-84.
  • Rowan RM, Bain BJ, England JM, et al. General Haematology Task Force of BCSH. Immunophenotyping in the diagnosis of chronic lymphoproliferative disorders. J Clin Pathol 1994; 47: 871-5.
  • Erber WN. Immunophenotypic analysis of haematological disorders. In: Haematology: Proceedings of International Society of Haematology 26th Congress. Singapore 1996; 328-34.
  • Jennings CD, Foon KA. Recent advances in flow cytometry: application to the diagnosis of haematologic malignancy. Blood 1997; 90: 2863-92.
  • Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361-92.
  • Batata A, Shen B. Relationship between chronic lymphocytic leukaemia and small lymphocytic lymphoma: a comparative study of membrane phenotypes in 270 cases. Cancer 1992; 70: 625-32.
  • Matutes E, Oscier D, Garcia-Marco J, et al. Trisomy 12 defines a group of CLL with atypical morphology: correlation between cytogenetic, clinical and laboratory features in S44 patients. Br J Haematol 1996; 92: 382-8.
  • Rozman C, Montserrat E. Chronic lymphocytic leukaemia. New Engl J Med 1995:333: 1052-7.
  • Huang JC, Finn WG, Variakojis D, et al. COS negative (-) chronic B cell leukaemias are rarely classified as B chronic lymphocytic leukaemia (B-CLL). Mod Pathol 1997; 10: 127a.
  • Huh YO, Pugh WC, Kantarajian HM, etal. Detection of subgroups of chronic B-cell leukaemias by FM CV monoclonal antibody. Am J Clin Pathol 1994; 101:283-9.
  • Weisenburger DD, Armitage JO. Mantle Cell Lymphoma: an entity comes of age. Blood 1996; 87: 4483-94.
  • Tbakhi A, EdingerM, Myles J, et al. Flow cytometric immunophenotyping of non-Hodgkin's lymphomas and related disorders. Cytometry 1996;25: 113-24.
  • Qin Y, Greiner A, Trunk MJF, et al. Somatic hypermutation in lowgrade mucosa-associated lymphoid tissue-type B-cell lymphoma. Blood 1995; 86: 3528-34.
  • Matutes E, Morilla R, Owusu-Ankomah K, et al. The immunophenotype of splenic lymphoma with villous lymphocytes and its relevance to the differential diangnosis with other B-cell disorders. Blood 1994; 83: 1558-62.
  • Robbins BA, Ellison DJ, Spinosa JC, et al. Diagnostic application of two-colour flow cytometry in 161 cases of hairy cell leukaemia. Blood 1993; 82: 1277-87.
  • de Totero D, Tazzari PL, Lauria F, et al. Phenotypic analysis of hairy cell leukaemia: varient cases express the interleukin-2 receptor b chain, but not the a chain (CD25). Blood 1993; 82: 528-35.
  • Seymour JF, Kurzrock R, Freireich EJ, Estey EH. 2-Chlorodeoxyadenosine induces durable remissions and prolonged supression of CD4+ lymphocyte counts in patients with hairy cell leukaemia. Blood 1994:83:2906-11.
  • Greer JP, Maeon WR, Lamar RE, et al. T-cell rich B-cell lymphomas: diagnosis and response to therapy of 44 patients. J Clin Oncol 1995; 13: 1742-50.
  • McBride JA, Rodriguez J, Luthea R, et al. T-cell rich B-cell large-cell lymphoma simulating lymphocyte-rich Hodgkin's disease. Am J Surg Pathol 1996:20: 193-201.
  • Kadin ME. Ki-1/CD30+ (anaplastic) large cell lymphoma: maturation of a clinicopathological entity with prospects of effective therapy. J Clin Oncol 1994; 12: 884-7.
  • Falini B, Pileri S. Pizzolo G, et al. CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunothreeapy. Blood 1995; 85: 1-14.
  • Borowitz MJ, Croker BP, Metzgar RS. Immunhistochemical analysis of the distribution of lymphocyte subpopulations in Hodgkin's disease. Cancer Treat Rep 1982; 66: 667-74.
  • Hummel M, Ziemann K, Lammert H, et al. Hodgkin's disease with monoclonal and polyclonal populations of Reed-Sternberg cells. New EnglJMed 1995; 333: 901-6.
  • Delabie J, Tierens A, Wu G, et al. Lymphocyte predominance in Hodgkin's disease: lineage and clonality determination using a single-cell assay. Blood 1994; 84: 3291-8.
  • Tatewaki M, Yamaguchi K, Matsuoka M, et al. Constitutive overexpression of the L-selectin gene in freash leukaemic cells of adult T-cell leukaemia that can be transactivated by human T-cell lymphotrophic virus type I tax. Blood 1995; 86: 3109-17.
  • Matutes E, Brito-Babapulle V, Swansbury J, et al. Clinical and laboratory features of 78 cases of T-prolymphocytic leukaemia. Blood 1991; 78: 3269-74.
  • Loughran TP. Clonal diseases of large granular lymphocytes. Blood 1993; 82: 1-14.
  • Gentile TC, Uner AH, Hutchison RE, et al. CD3 +, CD56 + agressive varient of large granular lymphocyte leukaemia. Blood 1994; 84: 2315-21.
  • Sallah S, Smith SV, Lony LC, et al. Gamma/delta T-cell hepatosplenic lymphoma: review of the literature, diagnosis by flow cytometry and concomitant autoimmune haemolytic anaemia. Ann Haematol 1997; 74: 139-42.
  • Tedder T, Clement L. Cooper M. Discontinuous expression of a membrane antigen (HB-7) during B-lymphocyte differentiation. Tissue Antigens 1984; 24: 140-9.
  • Witzig TE. Kimlinger TK, Ahmann GJ. et al. Detection of myeloma cells in the peripheral blood by flow cytometry. Cytometry 1996; 26: 113-20.
  • Sailer M, Vykoupil K-F. Peest D. et al. Prognostic significance of a histologie classification system applied in bone marrow biopsies from patients with multiple myeloma: a histopathological evaluation of biopsies from 163 untreated patients. Eur J Haematol 1995; 54: 137-46.
  • Zhang X. Galliard JP. Robbiard N. et al. Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myeloma. Blood 1994; 83: 3654-63.
  • Pope B, Brown RD. Gibson J. et al. The functional phenotype of the primitive plasma cell in patients with multiple myeloma correlates with the clinical state. Leak Lymph 1997; 27: 83-91.
  • Schneider U, van Lessen A, Huhn D, Serke S. Two subsests of peripheral blood plasma cells defined by differential expression of CD45 antigen. Br J Haematol 1997; 97: 56-64.
  • Harada Y. Kawano MM, Huang N. et al. Identification of early plasma cells in peripheral blood and their clinical significance. Br J Haematol 1996; 92: 181-91.
  • Wijdenes J, Vooijs WC, Clement C, et al. A plasmacyte selective monoclonal antibody (B-B4) recognises syndecan-1. Br J Haematol 1996; 94: 318-23.
  • Witzig TE. Dhodapkar MV, KyIe RA, Greipp PR. Quantitation of circulating peripheral blood plasma cells and their relationship to disease activity in patients with multiple myeloma. Cancer 1993; 72: 108-13.
  • Rawston AC, Owen RG, Davies FE, et al. Circulating plasma cells in multiple myeloma: characterisation and correlation with disease state. Br J Haematol 1997; 97: 46-55.
  • Rosse WF, Ware RE. The molecular basis of paroxysmal nocturnal hemoglobinuria. Blood 1995; 86: 3277-86.
  • Hall SE, Rosse WF. The use of monoclonal antibodies and flow cytometry in the diagnosis of paroxysmal nocturnal hemoglobinuria. Blood 1996; 87: 5332-40.
  • Rollins SA, Sims PJ. The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9. J lmmunol 1990; 144: 3478-83.
  • Hillmen P, Lewis SM1 Bessler M, et al. Natural history of paroxysmal nocturnal haemoglobinuria. New Engl J Med 1995; 333: 1253-8.
  • Rotoli B, Bessler M, Alfmito F. del Vecchio L. Membrane proteins in paroxysmal nocturnal haemoglobinuria. Blood Rev 1993; 7: 75-86.
  • K won g YL, Lee CP. Chan TK, Chan LC. Flow cytometric measurement of glycosylphosphatidyl-inositol-linked surface proteins on blood cells of patients with paroxysmal nocturnal haemoglobinuria clone in aplastic anaemia. Am J Clin Pathol 1994; 102: 30-5.
  • Campana D, Pui C-H. Detection of minimal residual disease in acute leukaemia: methodologie advances and clinical significance. Blood 1995; 85: 1416-34.
  • Stelzer GT. Flow cytometric analysis of hematological malignancy: multiparameter detection of residual tumor cells. Clin fmmunol 1996; 16: 143-50.
  • Miyamura K, Tahara T, Tanimoto M, et al. Long persistent bcr-abl positive transcript detected by polymerase chain reaction after marrow transplant for chronic myelogenous leukemia without clinical relapse: a study of 64 patients. Blood 1993; 81: 1089-93.
  • Terstappen LWMM, Safford M, Unterhalt M, et al. Flow cytometric characterization of acute myeloid leukaemia: IV. Comparison to the differentiation pathway of normal haemopoietic progenitor cells. Leukaemia 1992; 6: 993-1000.
  • Macedo A, Orfao A, Ciudad J, et al. Phenotypic analysis of CD34 subpopulations in normal human bone marrow and its application for the detection of minimal residual disease. Leukaemia 1995; 9: 1896-901
  • Farahat N, Lens D, Zomas A, et al. Quantitative flow cytometry can distinguish between normal and leukaemic B-cell precursors. Br J Haematol 1995; 91: 640-5.
  • Behm FG, Smith FO, Raimondi Sc, et al. Human homologue of the rat chondroitin sulfate proteoglycan, NG2, detected by monoclonal antibody 7.1, identifies childhood acute lymphoblastic leukaemia with t(4;ll)(q21;q23) or t(ll;19)(q23;pl3) and MLL gene rearrangements. Blood 1996; 87: 1134-9.
  • Campana D. Applications of cytometry to study acute leukaemia: In vitro determination of drug sensitivity and detection of minimal residual disease. Cytometry 1994; 18: 68-74.
  • Roberts WM, Estrov Z, Ouspenskaia MS, et al. Measurement of residual leukaemia during remission in childhood acute lymphoblastic leukaemia. New Engl 1 Med 1997; 336: 317-23.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.